It doesn't have enough ratings yet to judge what users think.
TransiMed App is made and published by
Ernesto Gavilanes Lara.
AppBrain is an independent app data site and isn't affiliated with Ernesto Gavilanes Lara.
The app name, icon, screenshots and description belong to Ernesto Gavilanes Lara and are shown as
published on the App Store.
About TransiMed App
TransiMed App is a navigation app developed by Ernesto Gavilanes Lara.
What is the rating of TransiMed App?
TransiMed App is rated 5.00 out of 5 stars, based on one rating ratings.
Is TransiMed App free?
TransiMed App is free. The app size is 37.90 MB. The latest version available is 1.0.11. The last update was on August 11, 2026.
What are the requirements for TransiMed App?
The app has a content rating of Everyone. The app has been available on the App Store since January 2025.
Description by Ernesto Gavilanes Lara(from the App Store)
TransiMed — NEMT Driver App
TransiMed is the all-in-one mobile app designed for Non-Emergency Medical Transportation (NEMT) drivers. Stay organized, connected, and compliant — all from your phone.
Key Features:
Accept and manage trip assignments in real time GPS-powered route tracking with live navigation View your daily schedule with pickup and drop-off details Upload and manage required documents (license, background check, certifications) Receive instant push notifications for new trips and schedule changes Biometric login for fast, secure access Dark mode support for comfortable use at any time Real-time communication with your dispatch team Built for NEMT professionals:
TransiMed streamlines your daily workflow so you can focus on what matters — safely transporting patients to their appointments. Whether you handle ambulatory, wheelchair, or stretcher trips, TransiMed keeps everything organized in one place.
Download now and take control of your NEMT operations.
Each subscription will automatically renew 3 days before the expiration date for
the same time period. Subscriptions can be cancelled at any time before the renewal.